Number of the records: 1
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
- 1.STUDENOVSKÝ, M., RUMLEROVÁ, A., KOVÁŘOVÁ, J., DVOŘÁKOVÁ, B., SIVÁK, L., KOSTKA, L., BERDÁR, D., ETRYCH, T., KOVÁŘ, M. HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo. Pharmaceutics. 2022, 14(6), 1201. E-ISSN 1999-4923. Available: doi: 10.3390/pharmaceutics14061201.
Number of the records: 1